LA JOLLA, Calif., Sept. 30, 2019 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the?NASDAQ Global Market?(NASDAQ:MNOV) and the JASDAQ Market of the?Tokyo Stock Exchange?(Code Number: 4875), today announced that it has rec… […]
SAN DIEGO, Sept. 30, 2019 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced positive topli… […]
Experts discuss AML during the Sanford Burnham Prebys community lecture series?
Bill Veljovich had never been sick in his life. ?Not even joint pain,? shared the 80-year-old retired engineer at our recent Fleet Science Center discussion about acute my… […]
BRISBANE, Calif.–(BUSINESS WIRE)–Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that members of the management team will present at the following investor and industry conferences in October: Cell & Gene Me… […]
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) and the Broad Institute of MIT and Harvard today announced they have entered into a collaboration for the co-development of secondary genomic analysis algorithms and software. Top data scientist… […]
SAN DIEGO, Sept. 27, 2019 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced that Hamza Sur… […]
As founder and engine of Ionis, Dr. Stanley T. Crooke changed medical history […]
No one would argue that San Diego is overflowing with venture capitalists in the way, say, the San Francisco Bay Area is. In fact, the region?s relative dearth of investors is often bemoaned by local entrepreneurs. But, at least once yearly, that chang… […]
DURHAM, N.C.–(BUSINESS WIRE)–Ribometrix, a biotechnology company developing small molecule therapeutics that directly target RNA to treat human diseases, today announced $7.8 million in additional funding from existing investors, the Dementia Discove… […]
Zingle, a startup whose software is used by hospitality, travel, and retail industries to more easily and quickly connect with their customers via messaging, has been acquired for about $42 million in cash by Medallia, a publicly traded software compan… […]
Longtime biomedical champion gets top Innovation Awards honor […]
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that Brandi L. Roberts, Ch… […]
Reports + Research UC San Diego Opens Center for Novel Therapeutics UC San Diego and BioMed Realty have opened a new building at UC San Diego?s Science Research Park to house the Center for Novel Therapeutics. The Center?s goal is to advance scientific… […]
Conference being held October 2nd- 4th, 2019 in Carlsbad; live video webcast available Conference being held October 2nd- 4th, 2019 in Carlsbad; live video webcast available […]
BASEL, Switzerland, Sept. 25, 2019 (GLOBE NEWSWIRE) — Axovant Gene Therapies Ltd. (Nasdaq: AXGT), a clinical-stage company developing innovative gene therapies, today announced that Parag Meswani, Pharm.D., senior vice president, commercial strategy… […]
While the headlines may be dominated by news of WeWork putting its IPO on hold after reports about its questionable corporate governance, the overall initial public offering market is doing just fine. So far, 127 US companies went public in the first n… […]
SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today ann… […]
SAN FRANCISCO & SAN DIEGO–(BUSINESS WIRE)– #ArenaPharmaceuticals–California Life Sciences Association (CLSA) Names 2019 Pantheon DiNA Award Winners, Recognizing Advancements in California Life Sciences. […]
SAN DIEGO–(BUSINESS WIRE)– #TCT2019–FIH data shows that RUC-4, a novel subcutaneous platelet GPIIb/IIIa inhibitor, resulted in a potent, rapid, and sustained platelet inhibition effect. […]
La Jolla, CA., Sept. 24, 2019 (GLOBE NEWSWIRE) — ?INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient?s innate immune system to fight disease, today announced that RJ Tesi, M.D., Co-Founde… […]
Called tolperisone, the drug showed effectiveness for back spasms with drowsiness comparable to placebo […]
SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), announced today that positive results from the Phase 2 CLARITY study evaluating pimavanserin as adjunctive treatment in patients with major depressive disorder (MDD) have been publ… […]
LA JOLLA?Colorectal cancer is a common lethal disease, and treatment decisions are increasingly influenced by which genes are mutated within each patient. Some patients with a certain gene mutation benefit from a chemotherapy drug called cetuximab, alt… […]
CRANBURY, N.J.–(BUSINESS WIRE)– #Animal–dvm360?, the No. 1 multimedia platform in the veterinary space, will host the final conference of its 2019 Fetch dvm360? conference series. The four-day educational veterinary continuing education meeting will… […]
SAN DIEGO, Sept. 23, 2019 (GLOBE NEWSWIRE) — Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, today announced that preclinical data for immuno-oncology produ… […]
LA JOLLA, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB), an immunotherapy company developing treatments which harness the patient?s innate immune system to fight disease, announced today that the company will be presentin… […]
SAN DIEGO–(BUSINESS WIRE)– #BayArea–Biocom, the association representing the California life science industry, today announced the winners of its Fourth Annual Catalyst Awards. […]
Bill Veljovich had never been sick in his life. ?Not even joint pain,? shared the 80-year-old retired engineer at our recent Fleet Science Center discussion about acute myeloid leukemia (AML), a life-threatening type of blood cancer. He was joined by e… […]
Copyright © 2021 Biotech Networks, LLC
